PCM
DVAX

Palouse Capital Management’s Dynavax Technologies DVAX Stock Holding History

Palouse Capital Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,260
Closed -$19.4K – 145
2025
Q4 		$19.4K Hold
1,260
– – 0.01% 128
2025
Q3 		$12.5K Hold
1,260
– – 0.01% 125
2025
Q2 		$12.5K Hold
1,260
– – 0.01% 119
2025
Q1 		$16.3K Hold
1,260
– – 0.01% 125
2024
Q4 		$16.1K Buy
+1,260
New +$15.2K 0.01% 134
2024
Q2 		– Sell
-1,260
Closed -$15.6K – 128
2024
Q1 		$15.6K Buy
+1,260
New +$16.4K 0.01% 126

Other funds holding DVAX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Palouse Capital Management's DVAX Position: Q1 2026 in Review

Palouse Capital Management sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 1,260 shares — an estimated $19.4K sold.

Palouse Capital Management first reported a position in DVAX in Q1 2024 and held it in 6 quarters. The position peaked at $19.4K in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Palouse Capital Management reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Palouse Capital Management sold 1,260 Dynavax Technologies shares in Q1 2026, an estimated $19.4K.
  • Palouse Capital Management first reported a position in Dynavax Technologies in Q1 2024 and held it in 6 quarters.
  • Palouse Capital Management's Dynavax Technologies position peaked at $19.4K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Palouse Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.